Business Description
Sirnaomics Ltd
ISIN : KYG2050P1028
Description
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.97 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | -0.22 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -26.2 | |||||
| 3-Year EPS without NRI Growth Rate | -32.3 | |||||
| 3-Year FCF Growth Rate | -58.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.14 | |||||
| 9-Day RSI | 56.85 | |||||
| 14-Day RSI | 48.98 | |||||
| 6-1 Month Momentum % | -72.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.51 | |||||
| Quick Ratio | 4.51 | |||||
| Cash Ratio | 3.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 9.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -46.71 | |||||
| ROA % | -31.43 | |||||
| ROIC % | -86.28 | |||||
| 3-Year ROIIC % | 84.31 | |||||
| ROC (Joel Greenblatt) % | -163.56 | |||||
| ROCE % | -38.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 0.94 | |||||
| EV-to-EBIT | -0.08 | |||||
| EV-to-EBITDA | -0.08 | |||||
| EV-to-FCF | -0.02 | |||||
| Price-to-Net-Current-Asset-Value | 1.6 | |||||
| Price-to-Net-Cash | 4.6 | |||||
| Earnings Yield (Greenblatt) % | -1351.16 | |||||
| FCF Yield % | -107.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sirnaomics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 48.98 | ||
| 14-Day ATR (€) | 0.021449 | ||
| 20-Day SMA (€) | 0.3267 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.28 - 3.475 | ||
| Shares Outstanding (Mil) | 86.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sirnaomics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sirnaomics Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sirnaomics Ltd Frequently Asked Questions
What is Sirnaomics Ltd(FRA:V5Z)'s stock price today?
The current price of FRA:V5Z is €0.37. The 52 week high of FRA:V5Z is €3.48 and 52 week low is €0.28.
When is next earnings date of Sirnaomics Ltd(FRA:V5Z)?
The next earnings date of Sirnaomics Ltd(FRA:V5Z) is .
Does Sirnaomics Ltd(FRA:V5Z) pay dividends? If so, how much?
Sirnaomics Ltd(FRA:V5Z) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers